ATOS Latest Headlines

Atossa Therapeutics: Buy Rating on Promising DMD Advancements and Strategic Growth Potential

at www.tipranks.com (Tue, 16-Dec 7:55 AM)

Promising Clinical Trial Results of Z-endoxifen Support Buy Rating for Atossa Therapeutics

at www.tipranks.com (Mon, 15-Dec 11:55 AM)

Atossa Therapeutics Secures FDA Rare Pediatric Disease Designation for (Z)-Endoxifen, Opening Door to Priority Review Voucher Opportunity

Market Chameleon (Thu, 11-Dec 10:35 AM)